Abstract
A radioreceptor assay (RRA) method is described to detect opioid peptides that uses a canine limbic system P2 receptor preparation and 3H-methionine enkephalin as the displaced ligand. In our laboratory, 3H-ME is a useful probe to detect the presence of, and to facilitate the description of, opioid peptides in biological extracts. Those opioid receptor-active peaks are then studied subsequently in greater detail with immunoassay and mass spectrometry methods. A variety of peptide ligands including leucine enkephalin, beta-endorphin, Tyr-D-Ala-GIy-NMe-Phe-Gly-OL (“DAGO”), Tyr-D-Ser-Gly-Phe-Leu-Thr (“delta-receptor peptide”), and several dynorphins (1–7, 1–8, 1–9, 1–10, 1–17, and B) were used to further characterize the molecular specificity of that RRA system.
Original language | English (US) |
---|---|
Pages (from-to) | 1865-1880 |
Number of pages | 16 |
Journal | Analytical Letters |
Volume | 21 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 1988 |
Externally published | Yes |
Keywords
- 3H-methionine
- enkephalin
- limbic system
- opioid
- peptide
- radioreceptorassay
ASJC Scopus subject areas
- Analytical Chemistry
- Biochemistry
- Spectroscopy
- Clinical Biochemistry
- Biochemistry, medical
- Electrochemistry